SPRO vs STE · P/E 9.6, rev $48.0M vs P/E 25, rev $5.46B
Spero Therapeutics Inc (SPRO) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
SPRO currently screens at market cap $149.5M and trailing P/E 9.6. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the SPRO and STE stock pages for the full models.
Not investment advice.